APA (7th ed.) Citation

Wanner, C., Heerspink, H. J., Zinman, B., Inzucchi, S. E., Koitka-Weber, A., Mattheus, M., . . . Groop, P. (2018). Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial. Journal of the American Society of Nephrology, 29(11), 2755-2769. https://doi.org/10.1681/ASN.2018010103

Chicago Style (17th ed.) Citation

Wanner, Christoph, et al. "Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial." Journal of the American Society of Nephrology 29, no. 11 (2018): 2755-2769. https://doi.org/10.1681/ASN.2018010103.

MLA (9th ed.) Citation

Wanner, Christoph, et al. "Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial." Journal of the American Society of Nephrology, vol. 29, no. 11, 2018, pp. 2755-2769, https://doi.org/10.1681/ASN.2018010103.